Prolyl hydroxylase-2 inhibits liver tumor cell proliferation and cyclin D1 expression in a hydroxylase-dependent manner

Author(s):  
Yifeng Tao ◽  
Feng Lin ◽  
Ruidong Li ◽  
Jie Shen ◽  
Zhengxin Wang
Endocrinology ◽  
1999 ◽  
Vol 140 (7) ◽  
pp. 3125-3132 ◽  
Author(s):  
Kazuaki Takabe ◽  
Jean-Jacques Lebrun ◽  
Yoji Nagashima ◽  
Yasushi Ichikawa ◽  
Masato Mitsuhashi ◽  
...  

2017 ◽  
Vol 2017 ◽  
pp. 1-11 ◽  
Author(s):  
Zhihui Xiao ◽  
Wenjun Wu ◽  
Vladimir Poltoratsky

Chronic inflammation is associated with cancer. CXCL8 promotes tumor microenvironment construction through recruiting leukocytes and endothelial progenitor cells that are involved in angiogenesis. It also enhances tumor cell proliferation and migration. Metformin, type II diabetes medication, demonstrates anticancer properties via suppressing inflammation, tumor cell proliferation, angiogenesis, and metastasis. This study intended to address the role of metformin in regulation of CXCL8 expression and cell proliferation and migration. Our data indicated that metformin suppressed LPS-induced CXCL8 expression in a dose-dependent manner through inhibiting NF-κB, but not AP-1 and C/EBP, activities under the conditions we used. This inhibitory effect of metformin is achieved through dampening LPS-induced NF-κB nuclear translocation. Cell migration was inhibited by metformin under high dose (10 mM), but not cell proliferation.


2009 ◽  
Vol 56 (4) ◽  
Author(s):  
Shuangshuang Dai ◽  
Yingru Zheng ◽  
Bin Chen ◽  
Min Gao ◽  
Yan Zhang ◽  
...  

Soluble APRIL (sAPRIL), the active form of a proliferation-inducing ligand (APRIL), is implicated in the proliferation of tumor cells. Suppressing APRIL function has been considered as a potential strategy for the therapy of APRIL-associated tumors. In the present study, we generated human sAPRIL and its two mutants, Gln187-D-sAPRIL (Gln187 deleted) and Gly187-sAPRIL (Gln187 replaced by Gly). In vitro experiments showed that the two mutants had similar specific binding capacity to lung carcinoma A549 cells compared to the wild-type sAPRIL, and both, especially Gly187-sAPRIL, exhibited significant antagonistic effect on sAPRIL-induced tumor cell proliferation in a dose-dependent manner, which might be predominantly mediated by blocking sAPRIL-induced MEK and ERK phosphorylation but not p38MAPK or JNK signaling. In vivo experiments with nude mice bearing A549 cell-derived xenograft tumor showed that only the Gly187-sAPRIL mutant could significantly suppress the tumor growth. These results suggest that Gln187 may be a crucial amino acid in APRIL-mediated tumor cell proliferation via the MEK-ERK signaling pathway and that the sAPRIL mutants may serve as novel potential antagonists of APRIL for the therapy of APRIL-associated cancers.


2014 ◽  
Vol 74 (22) ◽  
pp. 6661-6670 ◽  
Author(s):  
Jussara Hagen ◽  
Viviane P. Muniz ◽  
Kelly C. Falls ◽  
Sara M. Reed ◽  
Agshin F. Taghiyev ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document